A study published this month (September 2017) by researchers from the Department of Pharmacy, Health and Nutritional Sciences, at the University of Calabria in Rende, Italy, and from the Department of Health Sciences at the University Magna Graecia in Catanzaro, Italy, looked at the anti-cancer activity of lauric acid, the main fatty acid found in coconut oil. While coconut oil continues to get slandered in the U.S. by those with close ties to the pharmaceutical industry, research mainly outside the U.S. continues to show how healthy coconut oil can be, dispelling the common saturated-fat-is-bad myth still being promoted in the U.S. The study title is: "The lauric acid-activated signaling prompts apoptosis in cancer cells," and it was published in the journal "Cell Death Recovery." The study looked at the effects of lauric acid in both breast cancer and colon cancer: "The saturated medium-chain fatty-acid lauric acid (LA) has been associated to certain health-promoting benefits of coconut oil intake, including the improvement of the quality of life in breast cancer patients during chemotherapy. As it concerns the potential to hamper tumor growth, LA was shown to elicit inhibitory effects only in colon cancer cells. Here, we provide novel insights regarding the molecular mechanisms through which LA triggers antiproliferative and pro-apoptotic effects in both breast and endometrial cancer cells." Coconut oil is nature's richest source of lauric acid, by far, comprising almost 50% of the fatty acids in coconut oil. Human breast milk comes in a distant second at around 6% lauric acid. Lauric acid has a rich and long history of fighting pathogens, and has been a popular food preservative for many decades. Perhaps the most significant observation documented in this study was the ability of lauric acid to target cancer cells but not affect healthy cells, unlike most chemotherapy drugs: "Lauric Acid inhibited the viability of both cancer cell types without altering the growth of MCF-10A normal breast epithelial cells, thus suggesting its specific potential to trigger antiproliferative effects in malignant cells."
Las Grandes Compañías Farmacéuticas y los Principales Medios de Comunicación Atacan el Aceite de Coco con Información Errónea
En lo que parece ser un ataque coordinado contra la creciente popularidad del aceite de coco, la Asociación Americana del Corazón (AHA) acaba de publicar una "Asesoría Presidencial" sobre "Grasas en la Dieta y Enfermedades Cardiovasculares" en la que condena el aceite de coco y recomienda que las personas no lo consuman. La recomendación de la AHA contradice claramente investigaciones que existen no sólo sobre el aceite de coco, sino sobre las grasas saturadas en general, que desacreditan la vieja teoría de los lípidos en las enfermedades cardíacas, la cual dice que las grasas saturadas y el colesterol causan enfermedades del corazón. Sin embargo, los principales medios de comunicación financiados por corporaciones publicaron sus recomendaciones sin análisis crítico o investigaciones periodísticas sobre las afirmaciones de la AHA.
Among medical marijuana proponents there has been a lot of discussion about the various ways of combining coconut oil and cannabis as an ideal carrier for combining cannabis' external cannabinoids with the body’s internal cannabinoid system for healing. At first this combination was used to facilitate suppositories that when inserted rectally would somehow allow those who are THC intolerant to absorb full spectrum plant cannabis' benefits to be absorbed without the high. Then the coconut oil with cannabis was contained in capsules to create standardized cannabis edibles for medical consumption. This is what 77 year old Stan Rutner used to cure his terminal lung and brain cancer during hospice under his daughter Corrine’s and son-in-law John Malanca’s custody in California.
Forty percent of women today are obese. Many believe obesity is a precursor to diabetes, which if not reversed will lead to further health complications, and even be life threatening. However, a recent study looking at the effects of coconut oil on glycemia and inflammation demonstrated that obesity alone may not be the culprit. What the researchers discovered indicates that inflammation has a greater impact on insulin resistance and high blood sugar than excess fat. This could be argued, since adipose fats do release toxins over time that do create inflammation. But there are diabetes 2 patients who are not obese. Obesity in women has also been considered a factor in infertility, which this study also attempted to determine. Inadvertently, the study’s findings disclosed even more about the health protective qualities of coconut oil.
A recent 2017 study has determined that pure dietary saturated fats, especially coconut oil, can ease the suffering from inflammatory bowel diseases such as Crohn’s disease. This study was conducted at Case Western Reserve University in Cleveland, Ohio, a private institution well known for independent research. The study was reported in Science Daily June 22, 2017. Mice were fed only plant based fats such as cocoa butter and coconut oil. The mice fed coconut oil or cocoa butter had fewer kinds of gut bacteria. Their gut microbiome content had been positively altered to a healthier balance by 30 percent.
In what appears to be a coordinated attack against the rising popularity of coconut oil, the American Heart Association (AHA) has just published a "Presidential Advisory" on "Dietary Fats and Cardiovascular Disease" in which it condemned coconut oil, and recommended that people not consume it. The AHA's recommendation clearly contradicts research that exists on not only coconut oil but saturated fats in general, which debunks the old lipid theory of heart disease that saturated fat and cholesterol cause heart disease. Yet, the mainstream corporate-funded media published its recommendations with no critical analysis or journalistic investigations into the AHA's claims. Are these attacks against coconut oil part of an effort by Big Pharma to protect its $100 billion a year cholesterol lowering statin drug industry?
The saturated fat lie is officially exposed now that the British Journal of Sports Medicine, a division of the BMJ (British Medical Journal) emphatically declared: “Saturated fat does not clog the arteries: coronary heart disease is a chronic inflammatory condition, the risk of which can be effectively reduced from healthy lifestyle interventions.” The beginning of this very recent BMJ letter, 31 March 2017, reviewing several mega-studies, states early in their editorial: “Despite popular belief among doctors and the public, the conceptual model of dietary saturated fat clogging a pipe is just plain wrong.” Wrong, unequivocally and indisputably, not maybe or could be or further studies needed, but completely wrong. It’s over. And the root cause of arterial inflammation is cited with dietary recommendations that lean toward the Mediterranean Diet.
The health ramifications of virgin coconut oil keep surfacing from international studies without much coverage from mainstream media health or food sections. Fortunately, Health Impact News and their CoconutOil.com website is the leading authority today on the health benefits of coconut oil, keeping you up-to-date on all the published research about coconut oil you will never read in the mainstream corporate media. There has been a lot of text and talk about the wonders of coconut oil’s medium chain fatty acids and how they benefit the brain by producing ketones for brain cells’ functional nutrition. Ketones can even reverse Alzheimer’s disease. Of course, the pharmaceutical industry and their support of the mainstream media would like to keep that information from being known. There are even folks losing weight with high-fat ketogenic dieting, which includes the saturated fat coconut oil and other whole unadulterated healthy fats, to debunk the unscientific dogma of saturated fats as responsible for obesity. Many studies have demonstrated coconut oil’s antifungal and antibacterial capabilities as well. Now we have coconut oil demonstrating powerful antioxidant potential, even powerful enough for reducing the biological stress of chemotherapy. Here are two new studies that point this out.
Autism spectrum disorders (ASD) can include what are commonly defined as impeded social interactive developments and learning disorders. ASD could be as mild as hyperactivity and attention deficit or as extreme as total developmental shutdowns at early ages, little to no language abilities, and possibly chronic epileptic seizures. The ketogenic diet is simply one that restricts carbohydrates, especially refined carbohydrates, allows moderate or adequate protein intake, and enhances healthy organic dietary fat consumption. Categorizing the different factions of ASD psychologically unrealistically ignores the physiological aspects of ASD disorders. Instead, intense bowel and intestinal tract inflammations are listed as “co-morbid symptoms” and unrelated to ASD diagnostics. Not enough attention is placed on finding the underlying metabolic disorders involved in most cases of autism, which also produce the “co-morbid” symptoms. It’s already known that the ketogenic diet has positively impacted some with intractable epilepsy. Yet anti-seizure and anti-psychotic pharmaceuticals that at best merely control seizures without curing epilepsy are more commonly prescribed than monitored dietary changes. Not only do they have side effects, they create more metabolic disorders. Over the past two decades or so, more medical research has focused on the ketogenic diet’s potential for reducing the metabolic dysfunction that some consider as the root cause of many neurological diseases that plague us today.
Celebrity doctor Mehmet Oz exclaimed on national TV not long ago, “Alarm bells are ringing. The CDC estimates that one third of all Americans will develop diabetes and will live 15 years less and lose quality of life. No public health problem compares in scale.” The burgeoning diabetes epidemic comes mostly in the form of type 2 diabetes. Of the 29.1 million cases of diabetes estimated in 2014, only 1.25 million were type 1 diabetic, less than five percent. Type 2 diabetes is actually a life style disease, preventable with proper exercise and diet, and even reversible the same way. Pharmaceutical medications for type 2 diabetes rarely if ever improve that condition, and their side effects are actually precursors for other diseases, even cancer. A type 2 diabetic prescribed insulin will most likely become type 1 diabetic instead of curing type 2. Diabetes 2 is happening among a large portion of our population who are victims of SAD, the Standard American Diet of processed and fast foods as well as other poor and sedentary lifestyle choices. And injecting insulin for type 2 diabetics, though sometimes prescribed, is decried as the wrong approach by others who consider it like pouring kerosene on a fire to put it out.